Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
Clinical trial NCT02658084 · TERMINATED
Trial details
- NCT number
- NCT02658084
- Sponsor
- University of Miami
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-12
- Primary completion
- 2018-10-11
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.